Mechanisms of suppression by suppressor T cells

Nature Immunology

Volumn 6, Issue 4, 2005, Pages 338-344

  Von Boehmer, Harald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; SUPPRESSOR FACTOR; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; DIFFERENTIATION ANTIGEN; GRANZYME; GZMA PROTEIN, HUMAN; INTERLEUKIN 2; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN; SERINE PROTEINASE;

CELL CONTACT; CELL FUNCTION; CELL SURFACE; CYTOKINE RELEASE; EFFECTOR CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; HUMAN; IMMUNOLOGY; MOUSE; REGULATORY T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; GRANZYMES; HUMANS; INTERLEUKIN-2; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PORE FORMING CYTOTOXIC PROTEINS; SERINE ENDOPEPTIDASES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 16844362608     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1180     Document Type: Review

References (73)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
2. Fontenot, J.D. and Rudensky, A. A well adapted regulatory contrivance: regulatory T cell development and the Forkhead family transcription factor Foxp3. Nat. Immunol. 6, 338-344 (2005).
3. + T cell responses to a self peptide. Eur. J. Immunol. 30, 136-144 (2000).
4. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2, 301-306 (2001).
5. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
6. Apostolou, I., Sarukhan, A., Klein, L. & von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3, 756-763 (2002).
7. Gotter, J. & Kyewski, B. Regulating self-tolerance by deregulating gene expression. Curr. Opin. Immunol. 16, 741-745 (2004).
8. + T cell receptors. Immunity 21, 267-277 (2004).
9. Apostolou, I. & Von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 199, 1401-1408 (2004).
10. Chen, T.C., Waldmann, H. & Fairchild, PJ. Induction of dominant transplantation tolerance by an altered peptide ligand of the male antigen Dby. J. Clin. Invest. 113, 1754-1762 (2004).
11. + regulatory T cells by targeting of antigens to immature dendritic cells. Blood 101, 4862-4869 (2003).
12. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167, 188-195 (2001).
13. + T regulatory cells. Nat. Immunol. 4, 337-342 (2003).
14. + regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
15. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
16. Buer, J. et al. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187, 177-183 (1998).
17. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
18. O'Garra, A. & Vieira, P. Regulatory T cells and mechanisms of immune system control. Nat. Med. 10, 801-805 (2004).
19. Hu, D. et al. Analysis of regulatory CD8 T cells in Qa-1-deficient mice. Nat. Immunol. 5, 516-523 (2004).
20. + regulatory T cells in immunologic tolerance to self and non-self. Nat. Immunol. 6, 345-352 (2005).
21. Belkaid, Y. & Rouse, B.T. Natural T regulatory cells in infectious disease. Nat. Immunol. 6, 353-360 (2005).
22. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2, 389-400 (2002).
23. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194, 629-644 (2001).
24. + T cell suppressor function. Eur. J. Immunol. 34, 366-376 (2004).
25. + regulatory T cell function. Eur. J. Immunol. 34, 2480-2488 (2004).
26. Taylor, P.A. et al. B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions. J. Immunol. 172, 34-39 (2004).
27. Paust, S., Lu, L., McCarty, N. & Cantor, H. Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA 101, 10398-10403 (2004).
28. Mellor, A.L. & Munn, D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774 (2004).
29. Grossman, W.J. et al. Human T regulatory cells can use the perform pathway to cause autologous target cell death. Immunity 21, 589-601 (2004).
30. + T cell-mediated suppression by dendritic cells. Science 299, 1033-1036 (2003).
31. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
32. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol. 3, 135-142 (2002).
33. + T cells. J. Immunol. 173, 5008-5020 (2004).
34. Tone, M. et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc. Natl. Acad. Sci. USA 100, 15059-15064 (2003).
35. Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886-8891 (2003).
36. + regulatory T cells in the steady state. J. Exp. Med. 198, 737-746 (2003).
37. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
38. von Boehmer, H. Dynamics of suppressor T cells: in vivo veritas. J. Exp. Med. 198, 845-849 (2003).
39. Tang, Q. et al. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199, 1455-1465 (2004).
40. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199, 1467-1477 (2004).
41. Jaeckel, E., von Boehmer, H. & Manns, M. Antigen-specific Foxp3 transduced T cells can control established Type 1 diabetes. Diabetes 54, 306-310 (2005).
42. von Boehmer, H. Type 1 diabetes: focus on prevention. Nat. Med. 10, 783-784 (2004).
43. + cell Is controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173, 2942-2951 (2004).
44. + regulatory T cells. J. Exp. Med. 199, 303-313 (2004).
45. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
46. + T helper cells. J. Exp. Med. 196, 255-260 (2002).
47. Schorle, H., Holtschke, T., Hunig, T., Schimpl, A. & Horak, I. Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352, 621-624 (1991).
48. Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253-261 (1993).
49. Malek, T.R., Yu, A., Vincek, V., Scibelli, P. & Kong, L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 17, 167-178 (2002).
50. Van Parijs, L. & Abbas, A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 280, 243-248 (1998).
51. + T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol. 31, 1637-1645 (2001).
52. + T cell numbers. J. Immunol. 169, 4850-4860 (2002).
53. + regulatory T cell function. J. Exp. Med. 196, 851-857 (2002).
54. Malek, T.R. & Bayer, A.L. Tolerance, not immunity, crucially depends on IL-2. Nat. Rev. Immunol. 4, 665-674 (2004).
55. Bachmann, M.F., Kohler, G., Ecabert, B., Mak, T.W. & Kopf, M. Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131 (1999).
56. Bachmann, M.F. et al. Normal pathogen-specific immune responses mounted by CTLA-4-deficient T cells: a paradigm reconsidered. Eur. J. Immunol. 31, 450-458 (2001).
57. Bacchetta, R. et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179, 493-502 (1994).
58. Van Parijs, L. et al. Functional responses and apoptosis of CD25 (IL-2R α)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158, 3738-3745 (1997).
59. Sundstedt, A., O'Neill, E.J., Nicolson, K.S. & Wraith, D.C. Role for IL-10 in suppression mediated by peptide-induced regulatory T cells in vivo. J. Immunol. 170, 1240-1248 (2003).
60. + regulatory T cells. J. Immunol. 172, 5986-5993 (2004).
61. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
62. + T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)-and Th2-inducing cytokines. J. Exp. Med. 195, 603-616 (2002).
63. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166, 3008-3018 (2001).
64. Asseman, C., Mauze, S., Leach, M.W., Coffman, R.L. & Powrie, F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190, 995-1004 (1999).
65. + T cells. J. Autoimmun. 16, 115-123 (2001).
66. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100, 10878-10883 (2003).
67. Chen, M.L. et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-β signals in vivo. Proc. Natl. Acad. Sci. USA 102, 419-424 (2005).
68. + T cell function but not expansion. Nat. Immunol. 3, 1208-1213 (2002).
69. + immunoregulatory cells. J. Immunol. 167, 1137-1140 (2001).
70. + T cells. J. Immunol. 173, 6526-6531 (2004).
71. + T cell responses. J. Exp. Med. 198, 889-901 (2003).
72. Onizuka, S. et al. Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody. Cancer Res. 59, 3128-3133 (1999).
73. Yang, Y., Huang, C.T., Huang, X. & Pardoll, D.M. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CDS tolerance. Nat. Immunol. 5, 508-515 (2004).